Athletigen company

Athletigen is a leader in the performance genomics industry. Our DNA analysis solution allows elite athletes to develop one-size-fits-one training programs to achieve their athletic goals. This technology can be scaled to nutraceutical, pharmaceutical, medical, R&D, and apparel organizations that are looking to deliver personalized products for their customers.

Investors

Technology: P4 Medicine
Industry: Biotechnology, Health Care, Sports
Headquarters: Halifax, Nova Scotia, Canada
Founded Date: 2014-03-01
Employees Number: 11-50
Funding Status: Seed
Acquisitions Number: 1
Investors Number: 3
Total Funding: $1.6M
Estimated Revenue: $1M to $10M
Last Funding Type: Seed

Visit Website
contact@athletigen.com
https://twitter.com/Athletigen
Register and Claim Ownership